195 related articles for article (PubMed ID: 36097903)
1. [Pediatric pancreatic lesions: a clinicopathological analysis of 42 cases].
Gao Q; Xu H; Wang FH; Yi P; Yang TY; Li LP; Xia JQ; Zeng RX; Niu HL
Zhonghua Bing Li Xue Za Zhi; 2022 Sep; 51(9):861-867. PubMed ID: 36097903
[No Abstract] [Full Text] [Related]
2. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10.
Notohara K; Hamazaki S; Tsukayama C; Nakamoto S; Kawabata K; Mizobuchi K; Sakamoto K; Okada S
Am J Surg Pathol; 2000 Oct; 24(10):1361-71. PubMed ID: 11023097
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic and molecular characterizations of Sertoli cell tumor, not otherwise specified of the testis].
Zhao M; Zhao DH; He HY; Zhang X; Ru GQ; He XL; Wang Z; Teng XD
Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):505-510. PubMed ID: 29996314
[No Abstract] [Full Text] [Related]
4. [Expression and significance of INSM1 and SOX11 in pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm].
Cao Z; Cen HB; Zhao JH; Mei J; Qin LZ; Liao W; Ao QL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):575-581. PubMed ID: 37534634
[TBL] [Abstract][Full Text] [Related]
5. Pancreatoblastoma in an elderly woman: A case report simulating a pancreatic neuroendocrine tumour with emphasis on cytomorphological features.
Saoud C; Wu AA; Fishman EK; Hruban RH; Ali SZ
Cytopathology; 2023 May; 34(3):254-258. PubMed ID: 36546760
[TBL] [Abstract][Full Text] [Related]
6. Paranuclear dot-like immunostaining for CD99: a unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas.
Guo Y; Yuan F; Deng H; Wang HF; Jin XL; Xiao JC
Am J Surg Pathol; 2011 Jun; 35(6):799-806. PubMed ID: 21566515
[TBL] [Abstract][Full Text] [Related]
7. Nonductal Pancreatic Cancers.
Jun SY; Hong SM
Surg Pathol Clin; 2016 Dec; 9(4):581-593. PubMed ID: 27926361
[TBL] [Abstract][Full Text] [Related]
8. Pancreatoblastoma: Cytologic and histologic analysis of 12 adult cases reveals helpful criteria in their diagnosis and distinction from common mimics.
Reid MD; Bhattarai S; Graham RP; Pehlivanoglu B; Sigel CS; Shi J; Saqi A; Shirazi M; Xue Y; Basturk O; Adsay V
Cancer Cytopathol; 2019 Nov; 127(11):708-719. PubMed ID: 31581358
[TBL] [Abstract][Full Text] [Related]
9. Mixed acinar-endocrine carcinoma of the pancreas. A clinicopathological study and comparison with acinar-cell carcinoma.
Ohike N; Kosmahl M; Klöppel G
Virchows Arch; 2004 Sep; 445(3):231-5. PubMed ID: 15517367
[TBL] [Abstract][Full Text] [Related]
10. Title: pancreatic-type mixed acinar neuroendocrine carcinoma of the stomach: a case report and review of the literature.
Ooe Y; Watanabe K; Hashimoto I; Takenaka S; Ojima T; Yamamoto S; Fujii H
Diagn Pathol; 2021 Feb; 16(1):11. PubMed ID: 33531019
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evaluation of solid pseudopapillary tumors of the pancreas: the expression pattern of CD99 is highly unique.
Li L; Li J; Hao C; Zhang C; Mu K; Wang Y; Zhang T
Cancer Lett; 2011 Nov; 310(1):9-14. PubMed ID: 21775056
[TBL] [Abstract][Full Text] [Related]
12. Solid pseudopapillary neoplasms of the pancreas show an interruption of the Wnt-signaling pathway and express gene products of 11q.
Tiemann K; Heitling U; Kosmahl M; Klöppel G
Mod Pathol; 2007 Sep; 20(9):955-60. PubMed ID: 17632456
[TBL] [Abstract][Full Text] [Related]
13. Expression pattern of claudins 5 and 7 distinguishes solid-pseudopapillary from pancreatoblastoma, acinar cell and endocrine tumors of the pancreas.
Comper F; Antonello D; Beghelli S; Gobbo S; Montagna L; Pederzoli P; Chilosi M; Scarpa A
Am J Surg Pathol; 2009 May; 33(5):768-74. PubMed ID: 19194274
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic characterisitics of pancreatic acinar cell carcinomas].
Ding XH; Wang ZB; Qiu XM
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):274-278. PubMed ID: 29690667
[No Abstract] [Full Text] [Related]
15. Cytopathology of solid pancreatic neoplasms: An algorithmic approach to diagnosis.
Wang Q; Reid MD
Cancer Cytopathol; 2022 Jul; 130(7):491-510. PubMed ID: 35594486
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas.
Singhi AD; Lilo M; Hruban RH; Cressman KL; Fuhrer K; Seethala RR
Mod Pathol; 2014 Oct; 27(10):1355-63. PubMed ID: 24658583
[TBL] [Abstract][Full Text] [Related]
17. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
Kim MJ; Jang SJ; Yu E
Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
[TBL] [Abstract][Full Text] [Related]
18. Cytomorphologic and immunophenotypical features of acinar cell neoplasms of the pancreas.
Sigel CS; Klimstra DS
Cancer Cytopathol; 2013 Aug; 121(8):459-70. PubMed ID: 23408736
[TBL] [Abstract][Full Text] [Related]
19. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
20. [Clinical pathological analysis in 14 cases of pancreatic solid-pseudopapillary tumors].
Mei F; DU J; Ma XL
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Dec; 41(6):652-6. PubMed ID: 20019775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]